SHR-1819

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Atopic DermatitisSeasonal Allergic RhinitisPrurigo Nodularis

508 competitors in Atopic Dermatitis

#DrugCompanyPhaseTrials

1

Cytosar

Teva

Phase 3

12

Tagamet

DDT MedTech, LLC

Phase 3

13

Calcineurin Inhibitors

Sanofi

Phase 3

14

Elidel

Bayer

Phase 3

45

Verdeso

PPadagis LLC

Phase 3

16

SHR-1819

Guangdong Hengrui Pharmaceutical Co., Ltd

Phase 3

47

LNK01001

LLynk Pharmaceuticals Co., Ltd

Phase 3

28

Benvitimod

PPeking University People's Hospital

Phase 3

19

EBGLYSS

Eli Lilly

Preclinical

2310

Cibinqo

Pfizer

Preclinical

11Show 17 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Atopic Dermatitis4 trials

Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis

Active, not recruiting·Guangdong Hengrui Pharmaceutical Co., Ltd·Phase 3·NCT06468956·652 enrolled

A Phase III Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis

Not yet recruiting·Guangdong Hengrui Pharmaceutical Co., Ltd·Phase 3·NCT07309055·201 enrolled

A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis

Recruiting·Guangdong Hengrui Pharmaceutical Co., Ltd·Phase 2·NCT07321951·200 enrolled

Show 1 more trial

A Study to Extend Efficacy and Safety of SHR-1819 Injection in Adult Patients With Moderate to Severe Atopic Dermatitis

Completed·Shanghai Hengrui Pharmaceutical Co., Ltd.·Phase 2·NCT06012812·79 enrolled

Trial1 trial

A Trial of SHR-1819 in Healthy Subjects

Completed·AAtridia Pty Ltd.·Phase 1·NCT04561128·42 enrolled

Double-blind1 trial

A Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Study in Healthy Subjects

Completed·Shanghai Hengrui Pharmaceutical Co., Ltd.·Phase 1·NCT04772365·52 enrolled

Prurigo Nodularis1 trial

Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo Nodularis

Recruiting·Guangdong Hengrui Pharmaceutical Co., Ltd·Phase 2/3·NCT06554509·236 enrolled

Seasonal Allergic Rhinitis1 trial

A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis

Recruiting·Guangdong Hengrui Pharmaceutical Co., Ltd·Phase 2·NCT07091357·100 enrolled

2 more indications

Children and Adolescents With Moderate-to-severe Atopic Dermatitis1 trial

A Phase Ib/II Study to Investigate the Safety、PK and PD of SHR-1819 in Children and Adolescents With Moderate-to-severe Atopic Dermatitis

Completed·Guangdong Hengrui Pharmaceutical Co., Ltd·Preclinical·NCT06713499·51 enrolled

Unspecified1 trial

A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Devices in Healthy Subjects

Not yet recruiting·Guangdong Hengrui Pharmaceutical Co., Ltd·Phase 1·NCT07264335·160 enrolled

Details

Drug Info

Related News